Basic Info

AUScelerate is an independent, not-for-profit organisation established in 2015 to champion Australia’s life sciences sector by:

Backing start-ups, entrepreneurs and SMEs to bring new medical products from research labs to the market
Delivering innovation programs for state and federal governments
Helping Australian companies make international connections and access global markets through trade missions and strategic collaborations.

AUScelerate forges stronger connections between research and industry to help maximize opportunities for Australians to not only make scientific and technological breakthroughs, but to see them developed through the proof-of-concept stage and successfully translated and commercialised.

We achieve these outcomes with a focus on improving collaborations and commercialisation, funding cutting-edge innovations, improving management and workforce skills, optimising the regulatory and policy environment and improving access to global supply chains and strategic international markets.

AUScelerate also operates accelerator programs to support the development of cutting-edge medical technology, biotechnology and pharmaceutical innovations, with more than A$210 million invested so far in 213 projects.

Brochure

Company focus

Services

Company Type (Public/Private)

Industries

Government Relations

Health, Wellness and Fitness

International Trade and Development

Medical Devices

Projects or Case studies (2)

MTPConnect Sector Competitiveness Plan

Sector Competitiveness Plan In November of 2015, MTPConnect was established as an independent, not-for-profit organisation to drive connectivity, innovation, productivity and competitiveness in Australia’s medical technology, biotechnology and pharmaceuticals sector. The 2022 SCP, prepared in partnership with L.E.K. Consulting, shows growth across all key economic, commercial and R&D metrics, with particular strength in job creation. It also provides a progress report at the halfway point of our 10-year plan. It shows that between 2016 (when the first 10-year SCP was published) and 2021, Gross Value Added (GVA) has grown steadily at 2 per cent p.a., an additional 13,000 jobs have been created by the sector and the net number of MTP companies in Australia has increased by 100.

BioMedTech Horizons Program

The BMTH initiative supports the development of innovative collaborative health technologies, drives discoveries towards proof-of-concept and commercialisation that address key health challenges and maximises entrepreneurship and idea potential.

Contacts

Jarrod Belcher

Jo Glew

Executive Coordinator